Synthszr Charts — die großen AI-Marken im Wettkampf ums Podium
synthszr charts
arm

Arm · depuis 24. März 2026 · 14× · vu le 30 juin 2026

0
Momentum

The Arm AGI CPU is the first self-designed and sold production silicon in Arm Holdings' 35-year company history. It is based on up to 136 Neoverse V3 cores (Armv9.2 ISA) in a dual-chiplet design, co-developed with Meta as the lead partner, and manufactured on TSMC's 3nm process. The chip targets agentic AI workloads in data centers, acting as the orchestration layer for large-scale AI infrastructure. Commercial ordering opened at announcement; volume shipments are planned for H2 2026.

Historique du momentum
03.07.01.10.

Fonctionnalités

Manufacturing Process (nm)TSMC 3 nm
LicenseNo IP licensing model – Arm sells the AGI CPU as finished merchant silicon (proprietary product, sold directly by Arm; ~50% gross margin according to CFO Jason Child)
Release DateMarch 24, 2026 (announcement & order start); volume shipping H2 2026
AvailabilityOrderable since March 24, 2026 via OEM partners ASRock Rack, Lenovo, Supermicro; broader availability / volume production H2 2026; first revenue quarter: Q4 FY2027 (= Q4 2026 calendar year)

Plus de produits dans cette catégorie: Matériel d'inférence IA

Preuves (14)

Company Analysis: ARM

As of 30/09/2026
HOLDSynthszr Vote

Arm’s operating narrative is strong (record Q1 FY2027, sustained FY2026 royalty and licensing growth, and accelerating cloud AI/data-center positioning), but the equity’s valuation is exceptionally demanding (forward P/E ~119x per S&P Global-derived dataset). (investors.arm.com) With the stock priced for continued high growth and clean execution—especially as Arm expands into silicon products—the risk/reward is more balanced than the fundamentals alone suggest. Maintain exposure if you want AI/data-center CPU leverage, but size positions with the expectation of higher volatility and sensitivity to guidance, deal timing, and operating expense trajectory. (newsroom.arm.com)

Summary

Arm Holdings plc (NASDAQ: ARM) is a semiconductor IP company whose core business is licensing CPU/GPU and system IP (up-front license fees plus ongoing per-chip royalties) and, increasingly, selling higher-value platform solutions and design services. The model is structurally asset-light (no fabs), with economics driven by (1) the breadth of Arm’s ecosystem (software tools, developer base, OEM/ODM adoption) and (2) royalty rate per chip and mix shift toward higher-value end markets (cloud/data center, automotive, premium mobile). Market position remains dominant in smartphones and embedded/IoT, while the strategic growth vector is cloud AI/data centers via Arm Neoverse and custom hyperscaler silicon. In recent quarters Arm has emphasized accelerating data-center adoption and higher royalty rates per chip. A notable strategic development is Arm’s expansion from IP into silicon products: in March 2026 Arm announced its first Arm-designed data center CPU (“Arm AGI CPU”) aimed at “agentic AI infrastructure,” marking a material broadening of the company’s go-to-market and execution requirements. (newsroom.arm.com) Recent financial updates: Arm reported Q1 FY2027 (quarter ended June 30, 2026) results on July 29, 2026, highlighting record first-quarter total revenue and non-GAAP EPS of $0.45 (+29% YoY). Management reiterated data-center momentum and referenced securing manufacturing capacity to support a previously outlined $1B opportunity across FY2027–FY2028 (linked to its silicon initiative). (newsroom.arm.com) For FY2026, Arm disclosed royalty revenue of $2.61B (+21% YoY) and licensing revenue of $2.31B (+25% YoY), underscoring sustained >20% growth and mix improvement. (stockanalysis.com) Valuation is the central investor debate. As of Sep 29, 2026, third-party market data indicates a very high trailing P/E (~289x) and forward P/E (~119x), implying the market is discounting multi-year high growth and continued margin leverage. (stockanalysis.com) With the current ARM price at $285.75 (Sep 30, 2026), and using an EUR/USD reference around 1.1355 (ECB reference rate for Sep 29, 2026), the implied price is ~€251.7 per share (USD divided by EURUSD). (ecb.europa.eu) Outlook (short/medium term): near-term performance is primarily a function of (a) licensing deal timing/renewals, (b) royalty rate uplift and smartphone/consumer unit trends, and (c) the pace of cloud AI/data-center ramps. Medium-term, execution on the silicon expansion (productization, supply commitments, customer adoption) is a key swing factor for both growth and operating expense trajectory. (investors.arm.com)

Key Takeaways

  1. Arm’s asset-light IP model (licenses + royalties) continues to benefit from mix shift toward higher-value compute, particularly cloud AI/data centers, while maintaining a large mobile/embedded base. (investors.arm.com)
  2. Q1 FY2027 (ended Jun 30, 2026) delivered record first-quarter revenue and non-GAAP EPS of $0.45 (+29% YoY), supporting the narrative of sustained growth into FY2027. (newsroom.arm.com)
  3. FY2026 results showed royalty revenue of $2.61B (+21% YoY) and licensing revenue of $2.31B (+25% YoY), indicating broad-based momentum and higher royalty rates per chip. (datacenterdynamics.com)
  4. Strategic shift: Arm is moving beyond pure IP into silicon products (Arm AGI CPU), which can expand revenue pools but raises execution, cost, and customer/channel complexity. (newsroom.arm.com)
  5. Valuation remains demanding (forward P/E ~119x per S&P Global-derived dataset), increasing sensitivity to any growth deceleration, guidance conservatism, or operating expense re-acceleration. (stockanalysis.com)

Action Ideas

HOLD

Base-case positioning for investors who already own ARM: fundamentals show strong growth (record Q1 FY2027, continued data-center traction) but the equity is priced for sustained high growth and clean execution. With forward P/E around ~119x (per S&P Global-derived dataset), incremental upside requires continued beats and/or upward estimate revisions rather than merely meeting guidance. Maintain exposure while actively monitoring (1) royalty growth cadence vs licensing mix, and (2) operating expense trajectory tied to the silicon expansion and R&D intensity.

Horizon: 6 mo.

BUY

For investors with a 12–18 month horizon seeking exposure to cloud AI/data-center CPU share gains and royalty-rate uplift: Arm’s recent disclosures point to accelerating data-center transition and a defined multi-year opportunity tied to its silicon initiative (management referenced securing manufacturing capacity to support a $1B opportunity across FY2027–FY2028). If execution remains on track and data-center royalties continue to scale, the company can sustain above-market growth even if some legacy end markets are softer.

Horizon: 15 mo.

SELL

Risk-management action for valuation-sensitive investors: ARM’s market pricing implies a narrow margin for error. With trailing and forward P/E multiples at extreme levels (per third-party market data), any combination of slower royalty growth, weaker smartphone units, or higher-than-expected operating expense growth could lead to multiple contraction. Investors with large gains or low risk tolerance may reduce exposure until valuation better reflects near-term visibility.

Horizon: 3 mo.

Contrarian Insights

  • • Silicon expansion may be margin-dilutive before it is accretive: moving from IP licensing to shipping Arm-designed CPUs introduces supply-chain commitments and potentially higher operating expense intensity, which can delay operating margin expansion even if revenue grows. (newsroom.arm.com)
  • • The biggest near-term risk may be ‘good news already priced’: with forward P/E near ~119x, the stock can underperform even while Arm delivers record quarters, because the market may require accelerating (not just sustained) growth to justify the multiple. (stockanalysis.com)

Sources (7)

Subscribe free. Unsubscribe the second it sucks.

High-signal news across AI, business, UX, and tech. Every morning.